Tuning the Drug Efflux Activity of an ABC Transporter in vivo by in vitro Selected DARPin Binders

被引:16
|
作者
Seeger, Markus A. [1 ,2 ]
Mittal, Anshumali [2 ]
Velamakanni, Saroj [1 ]
Hohl, Michael [2 ]
Schauer, Stefan [3 ]
Salaa, Ihsene [1 ]
Gruetter, Markus G. [2 ]
van Veen, Hendrik W. [1 ]
机构
[1] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1QJ, England
[2] Univ Zurich, Dept Biochem, Zurich, Switzerland
[3] Univ Zurich, Funct Genom Ctr Zurich, Zurich, Switzerland
来源
PLOS ONE | 2012年 / 7卷 / 06期
基金
英国生物技术与生命科学研究理事会; 瑞士国家科学基金会;
关键词
MULTIDRUG-RESISTANCE; LACTOCOCCUS-LACTIS; ATP-BINDING; MEMBRANE-PROTEINS; CRYSTAL-STRUCTURE; RIBOSOME DISPLAY; REPEAT PROTEINS; FUNCTIONAL-ROLE; PHAGE DISPLAY; ANTIBODY;
D O I
10.1371/journal.pone.0037845
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
ABC transporters use the energy from binding and hydrolysis of ATP to import or extrude substrates across the membrane. Using ribosome display, we raised designed ankyrin repeat proteins (DARPins) against detergent solubilized LmrCD, a heterodimeric multidrug ABC exporter from Lactococcus lactis. Several target-specific DARPin binders were identified that bind to at least three distinct, partially overlapping epitopes on LmrD in detergent solution as well as in native membranes. Remarkably, functional screening of the LmrCD-specific DARPin pools in L. lactis revealed three homologous DARPins which, when generated in LmrCD-expressing cells, strongly activated LmrCD-mediated drug transport. As LmrCD expression in the cell membrane was unaltered upon the co-expression of activator DARPins, the activation is suggested to occur at the level of LmrCD activity. Consistent with this, purified activator DARPins were found to stimulate the ATPase activity of LmrCD in vitro when reconstituted in proteoliposomes. This study suggests that membrane transporters are tunable in vivo by in vitro selected binding proteins. Our approach could be of biopharmaceutical importance and might facilitate studies on molecular mechanisms of ABC transporters.
引用
收藏
页数:19
相关论文
共 50 条
  • [21] Evaluation of drug-transporter interactions using in vitro and in vivo models
    Xia, Cindy Q.
    Milton, Mark N.
    Gan, Liang-Shang
    CURRENT DRUG METABOLISM, 2007, 8 (04) : 341 - 363
  • [22] A fluorometric screening assay for drug efflux transporter activity in the blood-brain barrier
    Bachmeier, CJ
    Miller, DW
    PHARMACEUTICAL RESEARCH, 2005, 22 (01) : 113 - 121
  • [23] In Vitro Characterization of Renal Drug Transporter Activity in Kidney Cancer
    Caetano-Pinto, Pedro
    Justian, Nathanil
    Dib, Maria
    Fischer, Jana
    Somova, Maryna
    Burchardt, Martin
    Wolff, Ingmar
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (17)
  • [24] A Fluorometric Screening Assay for Drug Efflux Transporter Activity in the Blood-Brain Barrier
    Corbin J. Bachmeier
    Donald W. Miller
    Pharmaceutical Research, 2005, 22 : 113 - 121
  • [25] Combination of Tenofovir and Emtricitabine plus Efavirenz: In Vitro Modulation of ABC Transporter and Intracellular Drug Accumulation
    Bousquet, Laurence
    Pruvost, Alain
    Guyot, Anne-Cecile
    Farinotti, Robert
    Mabondzo, Aloise
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (03) : 896 - 902
  • [26] PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL OF TOPOTECAN TO VERIFY EFFLUX TRANSPORTER IN VITRO IN VIVO EXTRAPOLATION.
    Ning, M.
    Fang, Z.
    Hoeckels-Messemer, J.
    Riedmaier, A. Emami
    Bow, D. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S64 - S65
  • [27] Telatinib reverses chemotherapeutic multidrug resistance mediated by ABCG2 efflux transporter in vitro and in vivo
    Sodani, Kamlesh
    Patel, Atish
    Anreddy, Nagaraju
    Singh, Satyakam
    Yang, Dong-Hua
    Kathawala, Rishil J.
    Kumar, Priyank
    Talele, Tanaji T.
    Chen, Zhe-Sheng
    BIOCHEMICAL PHARMACOLOGY, 2014, 89 (01) : 52 - 61
  • [28] The Impact and In Vitro to In Vivo Prediction of Transporter-Based Drug-Drug Interactions in Humans
    Unadkat, Jashvant D.
    Kirby, Brian J.
    Endres, Christopher J.
    Zolnerciks, Joseph K.
    ENZYME- AND TRANSPORTER-BASED DRUG-DRUG INTERACTIONS: PROGRESS AND FUTURE CHALLENGES, 2010, : 517 - 553
  • [29] Confirmation of Selected Synergistic Cancer Drug Combinations Identified in an HTS Campaign and Exploration of Drug Efflux Transporter Contributions to the Mode of Synergy
    Kochanek, Stanton J.
    Close, David A.
    Wang, Allen Xinwei
    Shun, Tongying
    Empey, Philip E.
    Eiseman, Julie L.
    Johnston, Paul A.
    SLAS DISCOVERY, 2019, 24 (06) : 653 - 668
  • [30] In vitro and in vivo investigations on fluoroquinolones; effects of the P-glycoprotein efflux transporter on brain distribution of sparfloxacin
    de Lange, ECM
    Marchand, S
    van den Berg, DJ
    van der Sandt, ICJ
    de Boer, AG
    Delon, A
    Bouquet, S
    Couet, W
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2000, 12 (02) : 85 - 93